Back to 
BlackRock, Inc.
BlackRock, Inc.
NKTR5 quarters
Position history for BlackRock, Inc.'s holdings in Nektar Therapeutics
BlackRock, Inc. holds 2.9M shares of NKTR (Nektar Therapeutics), worth $205.4M as of 2026-Q2. The position was increased (+324.7% shares). NKTR represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$205.4M
Current Shares
2.9M
Total Value Change
+$194.6M
Total Shares Change
+2.5M
Quarter-by-Quarter History
Other major holders of NKTR: FMR LLC, VANGUARD CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP